AETHLON MEDICAL, INC.: 10-Q filed 2014-08-14

Name: AETHLON MEDICAL, INC.: 10-Q filed 2014-08-14
Creator: AETHLON MEDICAL, INC.

What AETHLON MEDICAL, INC. reported in its quarterly report filed 2014-08-14 (fiscal Q1 2015): 26 published measures, 53 facts as tagged in accession 0001019687-14-003149.

This filing

Form: 10-Q (quarterly report)
Filed: 2014-08-14
Fiscal period: fiscal Q1 2015
Accession: 0001019687-14-003149 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All AETHLON MEDICAL, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit
At 2014-06-30	1,144,448	USD
At 2014-03-31	1,695,102	USD
At 2013-06-30	195,243	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2014-06-30	4,665,304	USD
At 2014-03-31	16,425,268	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2014-06-30	-3,690,775	USD
At 2014-03-31	-14,948,436	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2014-04-01 to 2014-06-30	-3,655,941	USD	91
2013-04-01 to 2013-06-30	-303,498	USD	91

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2014-04-01 to 2014-06-30	51,296	USD	91
2013-04-01 to 2013-06-30	195,596	USD	91

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2014-06-30	-78,488,496	USD
At 2014-03-31	-74,832,557	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2014-04-01 to 2014-06-30	227,112,657	shares	91
2013-04-01 to 2013-06-30	176,221,634	shares	91

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2014-06-30	77,232	USD
At 2014-03-31	84,279	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2014-04-01 to 2014-06-30	170,887	USD	91
2013-04-01 to 2013-06-30	115,788	USD	91

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2014-04-01 to 2014-06-30	-1,172,008	USD	91
2013-04-01 to 2013-06-30	-783,798	USD	91

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2014-06-30	938,030	USD
At 2014-03-31	1,479,346	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2014-04-01 to 2014-06-30	-35,626	USD	91
2013-04-01 to 2013-06-30	106,096	USD	91

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2014-06-30	3,663,853	USD
At 2014-03-31	15,648,817	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2014-06-30	658,185	USD
At 2014-03-31	517,651	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2014-06-30	11,096	USD
At 2014-03-31	95,177	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2014-04-01 to 2014-06-30	1,223,304	USD	91
2013-04-01 to 2013-06-30	979,394	USD	91

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2014-04-01 to 2014-06-30	347,000	USD	91
2013-04-01 to 2013-06-30	338,000	USD	91

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2014-06-30	253,395,651	shares
At 2014-03-31	224,973,980	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2014-06-30	74,544,327	USD
At 2014-03-31	59,659,137	USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

Period	Value	Unit	Days
At 2014-06-30	-3,520,856	USD
At 2014-03-31	-14,730,166	USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

Period	Value	Unit	Days
At 2014-06-30	110,198	USD
At 2014-03-31	112,489	USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

Period	Value	Unit	Days
2014-04-01 to 2014-06-30	-3,704,292	USD	91
2013-04-01 to 2013-06-30	-303,498	USD	91

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2014-04-01 to 2014-06-30	201,005	USD	91
2013-04-01 to 2013-06-30	196,693	USD	91

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2014-04-01 to 2014-06-30	9,338	USD	91
2013-04-01 to 2013-06-30	2,436	USD	91

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2014-04-01 to 2014-06-30	320,800	USD	91
2013-04-01 to 2013-06-30	128,000	USD	91

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2014-04-01 to 2014-06-30	-84,081	USD	91
2013-04-01 to 2013-06-30	-208,781	USD	91

Inspect the source

Entity: AETHLON MEDICAL, INC. / CIK 0000882291
Captured: 2026-09-20T05:01:59.680Z
SEC response SHA-256: 8edef8396a760acc426ab35ab8234b202fee7f6b25b28f476090f7f70ae3999f

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000882291.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))